A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

BACKGROUND: Metastatic renal cell carcinoma (mRCC) had been a chemo-refractory disease, but recent advances in multiple kinase inhibitors such as sunitinib have dramatically changed the clinical course of mRCC. Sunitinib is used for mRCC chemotherapy based on the favorable results of a recent clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayoshi, Kotoe, Sagara, Kosuke, Uchino, Keita, Kusaba, Hitoshi, Sakamoto, Naotaka, Iguchi, Atsushi, Baba, Eishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491890/
https://www.ncbi.nlm.nih.gov/pubmed/26001650
http://dx.doi.org/10.1186/s12885-015-1443-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491890/
https://www.ncbi.nlm.nih.gov/pubmed/26001650
http://dx.doi.org/10.1186/s12885-015-1443-2

Ejemplares similares